Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis, IgA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07785128
What this trial is testing

Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA Nephropathy

Who this might be right for
IgA Nephropathy
Shaheed Suhrawardy Medical College and Hospital 104
Testing effectiveness (Phase 2)Study completedNCT00004448
What this trial is testing

Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy

Who this might be right for
IgA Glomerulonephritis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 96
Large-scale testing (Phase 3)Ended earlyNCT02647255
What this trial is testing

Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAKidney DiseasesAcute Renal Insufficiency+1 more
Peking University First Hospital 10
Not applicableLooking for participantsNCT05190848
What this trial is testing

Correlation of Microbiome and Metabonomics With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 600
Testing effectiveness (Phase 2)Ended earlyNCT05097989
What this trial is testing

Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyIgAN+1 more
Alexion Pharmaceuticals, Inc. 100
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Post-approval studies (Phase 4)UnknownNCT02571842
What this trial is testing

Rituximab in Recurrent IgA Nephropathy

Who this might be right for
Recurrent IgA Nephropathy
Chulalongkorn University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06797518
What this trial is testing

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

Who this might be right for
Glomerulonephritis, IGAImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06982040
What this trial is testing

Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Nanjing Chia-tai Tianqing Pharmaceutical 80
Not applicableLooking for participantsNCT01802034
What this trial is testing

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Who this might be right for
Kidney DiseasesKidney Failure, ChronicDiabetic Nephropathy+2 more
The Rogosin Institute 2,000
Post-approval studies (Phase 4)Study completedNCT00922311
What this trial is testing

Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade

Who this might be right for
IgA Nephropathy
The University of Hong Kong 25
Testing effectiveness (Phase 2)Ended earlyNCT04905212
What this trial is testing

Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy

Who this might be right for
IgA Nephropathy
RemeGen Co., Ltd. 15
Not applicableStudy completedNCT07607002
What this trial is testing

Assessing the Global Burden of IgA Nephropathy (IgAN) in Patients Receiving Hemodialysis: A Real-World Study Using DOPPS Data

Who this might be right for
IgAN - IgA Nephropathy
Arbor Research Collaborative for Health 70,000
Not applicableStudy completedNCT01838239
What this trial is testing

Development of a Metabolic Assessment Tool for Chronic Kidney Disease

Who this might be right for
Immunoglobulin A NephropathyHealthy Subjects
University of California, Davis 12
Early research (Phase 1)Ended earlyNCT00856674
What this trial is testing

Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy

Who this might be right for
IGA NephropathyProteinuria
Osprey Pharmaceuticals USA, Inc. 30
Large-scale testing (Phase 3)Active Not RecruitingNCT07098897
What this trial is testing

To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
The Affiliated Hospital of Xuzhou Medical University 150
Not applicableLooking for participantsNCT03001947
What this trial is testing

IgA Nephropathy Registration Initiative of High Quality (INSIGHT)

Who this might be right for
IgA Nephropathy
Sun Yat-sen University 10,000
Testing effectiveness (Phase 2)Study completedNCT06137768
What this trial is testing

A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 123
Very early researchLooking for participantsNCT07498673
What this trial is testing

YKST02 in Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Large-scale testing (Phase 3)UnknownNCT02187900
What this trial is testing

Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f.

Who this might be right for
IgA Nephropathy
Second Xiangya Hospital of Central South University 300
Next Page